Skip to main content

Advertisement

Table 1 Clinical features of colon cancer samples

From: Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients

   Non-responders Responders
Samples   28 (PD) 37
    7 (CR)
    19 (PR)
    11 (SD)
Age, years   58.3 57.9
Gender M 18 24
F 10 13
Localization R 6 1
L 21 34
  ND 1 2
Stage at first diagnosis I 2 0
II 1 5
III 5 2
IV 20 29
ND 0 1
Grade G1 2 3
G2 24 30
G3 1 1
ND 1 3
Treatment Cetuximab 23 29
Panitumumab 5 8
OS, average months   34.8 61.5
TTP, average months   3.6 14.9
  1. PD progressive disease, CR complete response, PR partial response, SD stable disease, M male, F female, R right colon, L left colon, OS overall survival, TTP time to progression, ND not determine